Evidence map›Paper›PMID 15004036›Full record

ReviewJournal of clinical microbiology2004

Recent developments for diagnosis of toxoplasmosis.

Jack S Remington, Philippe Thulliez, Jose G Montoya

Abstract readReview
In one paragraph

Review in Journal of clinical microbiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Seroprevalence and risk factors forParasite epidemiology and control · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Performances of ICT Toxoplasma IgG-IgM test in comparison with Vidas® toxo competition to determine the immune status against Toxoplasma gondii.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Comparisons ofArchives of Razi Institute · 2021
    Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jack S RemingtonDepartment of Immunology and Infectious Diseases, Research Institute, Palo Alto Medical Foundation, Palo Alto., California 94301, USA. samja@stanford.edu
Philippe Thulliez
Jose G Montoya

Funding

TOXOPLASMOSIS: NATURE OF INFECTION AND IMMUNE RESPONSER01AI004717 · NIAID · PALO ALTO MEDICAL FOUNDATION RES INST · PI REMINGTON, JACK S · 1985 to 2001
$1.1M
TOXOPLASMOSIS: NATURE OF INFECTION AND IMMUNE RESPONSER37AI004717 · NIAID · PALO ALTO MEDICAL FOUNDATION RES INST · PI REMINGTON, JACK S · 1987 to 1996
–
NIAID NIH HHS AI04717
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntibodies, ProtozoanAntibody AffinityHumansImmunoglobulin GImmunoglobulin MPolymerase Chain ReactionToxoplasmaToxoplasmosisAntibodies, ProtozoanImmunoglobulin GImmunoglobulin M

Identifiers

PMID15004036
PMCPMC356902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.